Loading...
XSHE
300122
Market cap6.49bUSD
Jun 06, Last price  
19.50CNY
1D
-2.16%
1Q
-22.03%
Jan 2017
18.40%
IPO
6.21%
Name

Chongqing Zhifei Biological Products Co Ltd

Chart & Performance

D1W1MN
P/E
5.78
P/S
0.88
EPS
3.37
Div Yield, %
4.10%
Shrs. gr., 5y
-0.52%
Rev. gr., 5y
58.87%
Revenues
52.92b
+38.30%
492,428,885590,335,676604,047,459737,313,591628,740,039764,619,690780,177,947800,937,517712,738,059445,947,1521,342,568,6325,228,307,72810,587,318,31115,190,366,23130,652,415,90638,264,011,33152,917,767,029
Net income
8.07b
+7.04%
152,009,074190,051,259231,589,722256,788,078196,383,625217,943,859130,347,838148,003,991197,401,92232,520,311432,275,4001,451,366,5282,366,438,7333,301,326,83010,208,548,4527,538,999,6978,069,868,204
CFO
9.00b
+352.30%
111,659,461141,584,417210,612,67454,190,253221,247,243112,891,820221,576,180161,388,660223,448,28389,954,889203,609,676585,590,1951,366,993,8303,496,688,9408,507,591,8171,989,033,1058,996,369,981
Dividend
Aug 08, 20240.8 CNY/sh

Profile

Chongqing Zhifei Biological Products Co., Ltd. engages in the research, development, manufacture, and marketing of vaccines and biological products in China. The company was founded in 2009 and is based in Chongqing, China.
URL
http://www.zhifeishengwu.com/
IPO date
Sep 28, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
52,917,767
38.30%
38,264,011
24.83%
Cost of revenue
41,651,452
28,579,251
Unusual Expense (Income)
NOPBT
11,266,315
9,684,761
NOPBT Margin
21.29%
25.31%
Operating Taxes
1,272,425
1,179,008
Tax Rate
11.29%
12.17%
NOPAT
9,993,890
8,505,752
Net income
8,069,868
7.04%
7,539,000
-26.15%
Dividends
(889,289)
(960,000)
Dividend yield
0.61%
0.70%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,635,483
1,794,721
Long-term debt
378,695
266,172
Deferred revenue
238,342
Other long-term liabilities
228,274
Net debt
(3,621,334)
(855,819)
Cash flow
Cash from operating activities
8,996,370
1,989,033
CAPEX
(1,134,172)
Cash from investing activities
(976,599)
Cash from financing activities
(4,293,867)
FCF
5,766,036
(842,517)
Balance
Cash
6,340,512
2,622,064
Long term investments
295,000
294,648
Excess cash
3,989,624
1,003,512
Stockholders' equity
31,458,116
24,028,248
Invested Capital
30,733,602
24,351,641
ROIC
36.29%
44.42%
ROCE
32.39%
38.11%
EV
Common stock shares outstanding
2,400,032
2,400,000
Price
61.11
7.15%
57.03
-54.23%
Market cap
146,665,967
7.16%
136,871,993
-54.23%
EV
143,044,633
136,016,174
EBITDA
11,604,700
9,999,704
EV/EBITDA
12.33
13.60
Interest
117,439
53,296
Interest/NOPBT
1.04%
0.55%